(Reuters) -Wall Street’s main indexes were down on Monday as investors await inflation data this week and chip companies ...

Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

Investing.com-- U.S. stocks stabilized Monday, pausing for breath after the previous week’s sharp gains, with investors ...

U.S. stock futures inched higher on Monday, with gains restrained ahead of key inflation data due later this week. Here are ...

US clinical-stage biotech Vor Bio has announced the appointment of Dallan Murray as chief commercial officer, effective ...

Vinay Prasad returns as FDA's CBER director after brief exit, raising questions on rare disease drug approvals and mRNA ...

Nvidia (NASDAQ: NVDA) stock fell 0.8% and AMD (NASDAQ: AMD) fell 1.8% after media reports suggested that the chipmakers are ...

Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration vaccine regulator Vinay Prasad will return to the agency.

Shares of International Money Express, Inc. IMXI +56.3% Get Free Report rose sharply in pre-market trading after Western ...

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investment and want to learn about a potential recovery under the federal ...